Literature DB >> 2831314

Modulation of neurotransmitter receptor desensitization: chlordiazepoxide stimulates fading of the GABA response.

D Mierlak1, D H Farb.   

Abstract

Benzodiazepines are neuromodulatory drugs that potentiate GABA-mediated conductance increases. We report the findings of an investigation into the effect of a full benzodiazepine-positive modulator (agonist), chlordiazepoxide (CDPX), on desensitization of the GABA response in chick spinal cord neurons maintained in primary monolayer cell culture. GABA application initially increases cell conductance, which then desensitizes. CDPX increases the apparent rate constant and extent of desensitization for the GABA response. The observed values for rate constant and extent of desensitization in the presence of CDPX are significantly greater than the values predicted for an equivalent peak response to GABA alone. Flunitrazepam, another full positive modulator, also stimulates the rate constant for GABA-induced desensitization. Furthermore, a weak partial benzodiazepine-positive modulator, Ro 15-1788 (an imidazodiazepine) (1) exhibits little or no potentiation of GABA-induced desensitization, and (2) antagonizes the ability of CDPX to stimulate GABA desensitization. The results demonstrate a novel form of neuromodulator action: the stimulation of receptor desensitization that cannot be explained by channel blockade. Thus, benzodiazepine modulators have the capacity to increase GABA receptor desensitization while increasing the peak response to GABA.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2831314      PMCID: PMC6569231     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  10 in total

1.  GABA-induced current and circadian regulation of chloride in neurones of the rat suprachiasmatic nucleus.

Authors:  S Wagner; N Sagiv; Y Yarom
Journal:  J Physiol       Date:  2001-12-15       Impact factor: 5.182

2.  The general anesthetic propofol slows deactivation and desensitization of GABA(A) receptors.

Authors:  D Bai; P S Pennefather; J F MacDonald; B A Orser
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

Review 3.  Molecular and cellular mechanisms of GABA/benzodiazepine-receptor regulation: electrophysiological and biochemical studies.

Authors:  M Farrant; T T Gibbs; D H Farb
Journal:  Neurochem Res       Date:  1990-02       Impact factor: 3.996

4.  Multiphasic desensitization of the GABAA receptor in outside-out patches.

Authors:  J J Celentano; R K Wong
Journal:  Biophys J       Date:  1994-04       Impact factor: 4.033

5.  Reduced GABA(A) receptor α6 expression in the trigeminal ganglion alters inflammatory TMJ hypersensitivity.

Authors:  J Puri; P Vinothini; J Reuben; L L Bellinger; L Ailing; Y B Peng; P R Kramer
Journal:  Neuroscience       Date:  2012-04-19       Impact factor: 3.590

6.  Molecular mechanisms of benzodiazepine-induced down-regulation of GABAA receptor alpha 1 subunit protein in rat cerebellar granule cells.

Authors:  M J Brown; D R Bristow
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

7.  Gamma-aminobutyric acid-immunoreactive neurons in the rat trigeminal nuclei.

Authors:  E Ginestal; C Matute
Journal:  Histochemistry       Date:  1993-01

8.  Use of 82Br- radiotracer to study transmembrane halide flux: the effect of a tranquilizing drug, chlordiazepoxide on channel opening of a GABAA receptor.

Authors:  D J Cash; P Serfözö; K Zinn
Journal:  J Membr Biol       Date:  1995-06       Impact factor: 1.843

9.  Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective GABA(A) Receptor Modulators?

Authors:  Christiaan H Vinkers; Berend Olivier
Journal:  Adv Pharmacol Sci       Date:  2012-03-29

10.  Cannabigerolic acid, a major biosynthetic precursor molecule in cannabis, exhibits divergent effects on seizures in mouse models of epilepsy.

Authors:  Lyndsey L Anderson; Marika Heblinski; Nathan L Absalom; Nicole A Hawkins; Michael T Bowen; Melissa J Benson; Fan Zhang; Dilara Bahceci; Peter T Doohan; Mary Chebib; Iain S McGregor; Jennifer A Kearney; Jonathon C Arnold
Journal:  Br J Pharmacol       Date:  2021-09-30       Impact factor: 9.473

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.